MEDIFAST (MED) Competitors $13.28 +0.02 (+0.14%) Closing price 03:58 PM EasternExtended Trading$13.27 -0.01 (-0.07%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MED vs. LW, NOMD, NUS, USNA, NATR, VERU, EL, PBH, IPAR, and HLFShould you be buying MEDIFAST stock or one of its competitors? The main competitors of MEDIFAST include Lamb Weston (LW), Nomad Foods (NOMD), Nu Skin Enterprises (NUS), USANA Health Sciences (USNA), Nature's Sunshine Products (NATR), Veru (VERU), Estee Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Interparfums (IPAR), and Herbalife (HLF). MEDIFAST vs. Its Competitors Lamb Weston Nomad Foods Nu Skin Enterprises USANA Health Sciences Nature's Sunshine Products Veru Estee Lauder Companies Prestige Consumer Healthcare Interparfums Herbalife Medifast (NYSE:MED) and Lamb Weston (NYSE:LW) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability. Does the media refer more to MED or LW? In the previous week, Lamb Weston had 2 more articles in the media than Medifast. MarketBeat recorded 5 mentions for Lamb Weston and 3 mentions for Medifast. Medifast's average media sentiment score of 0.45 beat Lamb Weston's score of 0.43 indicating that Medifast is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medifast 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lamb Weston 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate MED or LW? Medifast presently has a consensus price target of $16.50, indicating a potential upside of 24.26%. Lamb Weston has a consensus price target of $65.70, indicating a potential upside of 2.33%. Given Medifast's higher probable upside, equities research analysts clearly believe Medifast is more favorable than Lamb Weston.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medifast 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Lamb Weston 1 Sell rating(s) 8 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.23 Which has more risk and volatility, MED or LW? Medifast has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, Lamb Weston has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Which has higher valuation and earnings, MED or LW? Lamb Weston has higher revenue and earnings than Medifast. Lamb Weston is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedifast$602.46M0.24$2.09M$0.3241.50Lamb Weston$6.45B1.39$357.20M$2.0930.72 Do insiders and institutionals hold more shares of MED or LW? 95.5% of Medifast shares are held by institutional investors. Comparatively, 89.6% of Lamb Weston shares are held by institutional investors. 2.9% of Medifast shares are held by company insiders. Comparatively, 0.3% of Lamb Weston shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is MED or LW more profitable? Lamb Weston has a net margin of 4.56% compared to Medifast's net margin of 0.76%. Lamb Weston's return on equity of 28.08% beat Medifast's return on equity.Company Net Margins Return on Equity Return on Assets Medifast0.76% 2.00% 1.50% Lamb Weston 4.56%28.08%6.47% SummaryLamb Weston beats Medifast on 10 of the 16 factors compared between the two stocks. Get MEDIFAST News Delivered to You Automatically Sign up to receive the latest news and ratings for MED and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MED vs. The Competition Export to ExcelMetricMedifastFOOD IndustryStaples SectorNYSE ExchangeMarket Cap$145.94M$8.08B$15.68B$21.83BDividend YieldN/A3.92%3.26%3.67%P/E Ratio41.5022.6317.6329.93Price / Sales0.242.0948.0691.78Price / Cash4.5212.5214.3717.79Price / Book0.693.637.104.69Net Income$2.09M$395.13M$678.09M$1.01B7 Day Performance-3.98%-0.26%-0.85%0.13%1 Month Performance-5.01%1.11%-1.25%1.50%1 Year Performance-23.46%1.36%-1.55%14.25% MEDIFAST Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEDMEDIFAST3.4499 of 5 stars$13.28+0.1%$16.50+24.3%-26.4%$145.74M$602.46M41.50870LWLamb Weston4.3871 of 5 stars$63.39+0.8%$65.70+3.6%-10.5%$8.77B$6.45B30.3310,100NOMDNomad Foods4.8078 of 5 stars$12.79-2.3%$19.75+54.4%-31.3%$2.01B$3.35B8.767,788NUSNu Skin Enterprises3.629 of 5 stars$11.47+0.9%$6.88-40.1%+67.1%$562.79M$1.73B5.713,100Analyst UpgradeUSNAUSANA Health Sciences4.6961 of 5 stars$26.61-2.0%$36.00+35.3%-42.5%$496.26M$854.50M14.781,700News CoverageEarnings ReportUpcoming EarningsAnalyst DowngradeAnalyst RevisionNATRNature's Sunshine Products3.7112 of 5 stars$15.20-2.0%$20.50+34.9%+11.6%$273.53M$454.36M20.54850News CoveragePositive NewsVERUVeru2.4231 of 5 stars$4.01+5.5%$33.33+731.3%-52.2%$55.70M$16.89M-1.82230ELEstee Lauder Companies3.9463 of 5 stars$88.67+0.7%$88.55-0.1%-3.7%$31.68B$14.33B-28.2457,000News CoverageAnalyst UpgradePBHPrestige Consumer Healthcare4.4256 of 5 stars$63.26-1.1%$94.80+49.9%-11.1%$3.15B$1.14B14.85540Analyst ForecastIPARInterparfums4.2115 of 5 stars$93.41-1.2%$162.00+73.4%-25.5%$3.04B$1.45B18.72530HLFHerbalife3.9424 of 5 stars$8.83+2.0%$11.50+30.2%+24.9%$892.90M$4.99B2.798,600News Coverage Related Companies and Tools Related Companies LW Competitors NOMD Competitors NUS Competitors USNA Competitors NATR Competitors VERU Competitors EL Competitors PBH Competitors IPAR Competitors HLF Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MED) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you want a way to generate consistent market income without chasing volatile AI stocks or complex crypto tr...Base Camp Trading | SponsoredWhat the hell is going on, America?America’s $37.5 trillion debt spiral, soaring deficits, and repeated credit downgrades are exactly what Porter...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEDIFAST INC Please log in to your account or sign up in order to add this asset to your watchlist. Share MEDIFAST With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
